Post-pandemic respiratory infections in children born during or before the COVID-19 pandemic: a nationwide cohort study in Sweden.

Post-pandemic respiratory infections in children born during or before the COVID-19 pandemic: a nationwide cohort study in Sweden.

Publication date: Aug 01, 2026

Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic altered the circulation of respiratory pathogens. Following an initial decline in infections, a resurgence occurred as restrictions eased. We aimed to determine whether reduced early-life exposure to pathogens increased the risk of severe respiratory infections. In this longitudinal nationwide population-based study in Sweden, we compared a pandemic birth cohort of children born in Sweden between March 1 and December 31 from 2020 (n = 92,791) with aligned pre-pandemic cohorts born between 1 March and December 31 of 2015 (n = 94,552) and of 2018 (n = 96,074). Children with missing covariate data, death, or emigration before the age of two were excluded (10.5%). Baseline characteristics for the first two years of life were summarized. Outcomes were assessed between ages 2-4 years. Hospitalization for overall and specific lower respiratory tract infections (LRTI) was analysed as a binary outcome using logistic regression. Children born in 2020 had markedly lower hospitalisation rates during their first two years of life than both pre-pandemic cohorts. However, between ages 2 and 4, they exhibited significantly higher hospitalisation risk compared with both pre-pandemic cohorts. Adjusted odds ratio (aOR) for hospitalisation in the 2020 versus 2015 cohort were: all-cause LRTI (2.51 (95% CI 2.26-2.79)), influenza (2.99, 2.38-3.79) and respiratory syncytial virus (RSV) (4.36, 3.60-5.31). Similar patterns were observed for all-cause pneumonia and mycoplasma. The 2018 cohort showed a more mixed pattern, with lower risk for pneumonia but higher risk for RSV. Children born during the COVID-19 pandemic initially had a reduced risk of hospitalisation for respiratory infections, followed by a substantially increased risk in the post-pandemic period compared to children born before the pandemic. These findings suggest that altered early-life microbial exposure due to pandemic-related restrictions may influence subsequent patterns of severe childhood infections through immunological or exposure-related mechanisms and emphasis the need for further research to elucidate underlying mechanisms. The SCIFI-PEARLS project has basic fundings from the Swedish government and the county councils, the ALF agreement, the Swedish Research Council for Health, Working Life and Welfare, (Forte), and previously a joint grant from Forte-and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas).

Open Access PDF

Concepts Keywords
Child health
COVID-19
Immune debt
Non-pharmaceutical interventions
Respiratory infections

Semantics

Type Source Name
disease MESH respiratory infections
disease MESH COVID-19 pandemic
disease MESH infections
disease MESH death
disease MESH influenza
disease MESH pneumonia
drug DRUGBANK Coenzyme M
disease MESH infectious diseases
disease MESH strain
disease MESH pertussis
pathway KEGG Pertussis
drug DRUGBANK Isoxaflutole
disease MESH SCFI
drug DRUGBANK Pearl (hyriopsis cumingii)
disease MESH birth weight
disease MESH respiratory syncytial virus infection
disease MESH included
disease MESH pyothorax
disease MESH pneumococcal infection
disease MESH ICD
disease MESH dar
disease MESH asthma
pathway KEGG Asthma
disease MESH palsy
disease MESH bronchopulmonary dysplasia
disease MESH chromosomal abnormalities
disease MESH bacterial pneumonia
disease MESH mycoplasma infection
disease MESH viral infections

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *